University of Minnesota. Driven to Discover.
Merck's rVSV-ZEBOV is the only vaccine that will be used during the ever-growing outbreak in North Kivu and Ituri provinces.
Also, a high-level meeting was held in Geneva today to assess the latest developments and build donor support.
The grandmother of the 5-year-old boy identified in Uganda has also died, and the family cluster is at 8 cases.
"An enhanced UN-wide response is required. . . . We have no time to lose," says David Gressly.
The outbreak has reached 1,495 cases and 984 deaths, including 406 cases and 308 deaths in April.
Traditional chiefs and local officials took new steps to ease community resistance to response efforts.
Three new cases lift the outbreak total to 888, and officials say to expect more.
WHO officials see some traction with community engagement and calmed tensions, but tough challenges finding and chasing all transmission chains.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.